REPROSOME
LIVE

Serial Number

79361729

Owner

STEMON Inc.

Attorney

Jong Park

Filing Date

Dec 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

REPROSOME Trademark

Serial Number: 79361729 • Registration: 7445199

REPROSOME is a trademark filed by STEMON Inc. on December 20, 2022. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

STEMON Inc. (4 trademarks)

1161-1166, 11th Floor,

Entity Type: 03

Trademark Details

Filing Date

December 20, 2022

Registration Date

July 16, 2024

Published for Opposition

April 30, 2024

Goods & Services

Functional shampoo for hair loss; functional cosmetics being skin care preparations; anti-aging skin care preparations; anti-aging cosmetic preparations; eye wrinkle removing creams; shampoo for the care of scalp; cosmetics for scalp; massage gel; massage oils and lotions; make-up; body and beauty care cosmetics; cosmetic preparations for skin care; perfume; toilet soaps; mask pack for cosmetic purposes; cosmetics

Reagents for scientific or medical research use; cell growth media for growing cells for use in scientific research; biological preparations for scientific or laboratory purposes; cells for scientific or laboratory purposes; chemicals for scientific purposes other than for medical or veterinary use; chemicals for use in biotechnological manufacturing processes; biological preparations for use in biotechnology other than medical; reagents for cell transformation; exosome isolation reagent for non-medical use; stem cells for research or scientific purposes; biochemical additives for use in the manufacture of cosmetics

Exosome isolation reagent for medical use; exosomes for medical use; biological preparations for medical or veterinary purposes; living cells for medical purposes; pharmaceutical preparations for the treatment of Inflammatory diseases, Regenerative disease, Infectious disease, Immune-related diseases, Respiratory disease, Ocular disease, Cancer, Metastatic disease, Cardiovascular disease,Neurodegenerative disease, and Metabolic disease; stem cells for medical purposes; medicated creams; antibodies for medical purposes; pharmaceutical preparation for skin care

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 23, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 23, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 17, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 3, 2024 OPNX
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 16, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 12, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 12, 2024 OPNR
NOTIFICATION PROCESSED BY IB
Apr 30, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 30, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 10, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 10, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 27, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 4, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 26, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 25, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 10, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 3, 2023 REPR